Advanced approaches in insulin delivery

Current Pharmaceutical Biotechnology

Volumn 6, Issue 5, 2005, Pages 387-395

  Shaikh, I M ^a   Jadhav, K R ^a   Ganga, S ^a   Kadam, V J ^a   Pisal, S S ^b  

^a BHARATI VIDYAPEETH S COLLEGE OF PHARMACY   (India)

^b BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Alternative approaches; Diabetes; Diabetes vaccine; Gene therapy; Insulin delivery; Islet cell transplantation

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; ASPART; BIGUANIDE DERIVATIVE; CHITOSAN; DNA VACCINE; EUDRAGIT; FATTY ACID; GLARGINE; GLUCOSE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; IMMUNOSUPPRESSIVE AGENT; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN GLARGINE; INSULIN LISPRO; INSULIN RECEPTOR; INSULIN ZINC SUSPENSION; INTERLEUKIN 2; INTERLEUKIN 4; ISOPHANE INSULIN; LENTE; LIPOSOME; METFORMIN; PANCREAS HORMONE; PIOGLITAZONE; PREPROINSULIN; RAPAMYCIN; SULFONYLUREA; TOLBUTAMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; AREA UNDER THE CURVE; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE CLASSIFICATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRY POWDER; ENZYME INHIBITION; ENZYME STRUCTURE; GENE TRANSFER; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; METABOLIC DISORDER; MICROENCAPSULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PAIN; PANCREAS ISLET TRANSPLANTATION; POWDER INHALER; PROTEIN SYNTHESIS INHIBITION; RETROVIRUS; REVIEW; SIDE EFFECT; SUPPOSITORY; TABLET FORMULATION; VIRAL GENE DELIVERY SYSTEM;

DIABETES MELLITUS; DRUG ADMINISTRATION ROUTES; DRUG DELIVERY SYSTEMS; GENE THERAPY; HUMANS; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE;

EID: 27844550418     PISSN: 13892010     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920105774370599     Document Type: Review

References (121)

1. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2001) Diabetes Care, 24(2), S5-S20.
2. American Diabetes association. Economic consequences of diabetes mellitus in the U.S. in 1997 (1998) Diabetes Care, 31, 296-309.
3. Decourten, M.; Bennet, P.H.; Tuomilehto, J. and Zimmet, P. (1997) Epidemiology of NIDDM in non europids In: International Textbook of Diabetes Mellitus, K.G.M.M. Alberti, P. Zimmet, R.A. DeFronzo (Eds.). John Wiley: Chichester, UK, 143-70.
4. Zimmet, P. (1999) Diabetologia, 44, 499-518.
5. Jeffrey, W.M.; Fredric B.K. (2000) Endocrine and Metabolic Disorders: Diabetes Mellitus. Melmon K.L.; Nierenberg, D.W.; Hoffman, Carrythers S.G., Eds, Melmon and Morrellis Clinical Pharmacology basic principles in therapeutics. 4rth ed. Mc-Graw, Inc. pp. 529.
6. Koda-Kimble, M,A. and Carlisle, B.A. (2001) Diabetes Mellitus. In: Koda-Kimble, M.A.; Young, L.Y., Eds. Applied Therapeutics. The Clinical Use of Drugs, 7th ed. Vancouver, Wash: Applied Therapeutics, Inc.; chap 48.
7. Rosskamp, R.H. and Park, G. (1999) Diabetes Care, 22(2), 109-113.
8. Skyler, J.S.; Cefalu, W.T.; Kourides, I.A.; Landschulz, W.H.; Balagtas, C.C.; Cheng, S. and Gelfand, R.A. (2001) Lancet, 357, 331-335.
9. Cefalu, W.T.; Skyler, J.S.; Kourides, I.A.; Landschulz, W.H.; Balagtas, C.C.; Cheng, S. and Gelfand, R.A. (2001) Ann. Intern. Med., 134, 203-207.
10. DeFronzo, R.A. (1999) Ann. Intern. Med., 131, 281-303.
11. Vigneri, R.; Gallo, D. and Pezzino, V. (1984) Diabetes Care, 7(1), 113-7.
12. Banting, F.G. and Best, C.H. (1922) J. Lab. Clin. Med., 7, 464.
13. Canada JR, editor. USP dictionary of USAN and international drug names 1998. Rockville, MD: The United States Pharmacopeial Convention Inc., 1997, 379-80.
14. Hildebrand, P. (1991) Dan. Med. Bull., 38(4), 337-46.
15. Yang, S.Z.; Huang, Y.D.; Jie, X.F.; Feng, Y.M. and Niu, J.Y. (2000) World J. Gastroentero., 6(3), 371-373.
16. Koda-Kimble, M.A. (1992) Diabetes mellitus. In: Young, L.Y.; Koda-Kimble, M.A., Eds. Applied therapeutics: The clinical use of drugs. 5th ed. Vancouver, Wash: Applied Therapeutics Inc. p. 72(1)-72(53).
17. Nolte, M.S. (1992) Endocrinol. Metab. Clin. North Am., 21(2), 281-312.
18. Kahn, C.R. and Shechter, Y. (1990) Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. Goodman, A.G.; Tall, T.W.; Nies, A.S. and Taylor, P. Eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press; p. 1463-84.
19. Sodoyez, J.C.; Sodayez-Goffaaux, F.; Guillaume, M. and Merchie, G. (1983) Science, 219, 865-867.
20. Robbins, D.C.; Tager, H.S. and Rubenstein, A.H. (1984) N. Engl. J. Med., 310, 1165-1175.
21. Duckworth, W.C. (1988) Endocr. Rev., 9, 319-345.
22. Rabkin, R.; Ryan, M.P. and Duckworth, W.C. (1984), Diabetologia, 27, 351-357.
23. Hanks, J.B.; Andersen, D.K.; Wise, J.E.; Putnam, W.S.; Meyers, W.C. and Jones, R.S. (1984) Endocrinology, 115, 1011-1018.
24. Berman, M.; Mcguire, E.A.; Roth, J. and Zelenik, A.J. (1980) Diabetes, 29, 50-59.
25. King, G.L. and Johnson, S.M. (1985) Science, 227, 1583-1586.
26. Sieber, R.; Kamber, B.; Hartman, A.; Riniker, B.; and Rittel, W. (1974) Helv. Chem. Acta, 57, 2617.
27. Sieber, R.; Kamber, B.; Hartman, A.; Riniker, B.; and Rittel, W. (1977) Helv. Chem. Acta, 60, 27.
28. Keen, H.; Pickup, J.C.; Bilous, R.W.; Glynne, A.; Viberti, G.C. and Jarret, L.J. (1980) Lancet, 2, 398.
29. Goeddel, D.V.; Kleid, D.G. and Bolivar, F. (1979) Proc. Natl. Acad. Sci. USA, 76, 106.
30. Chance, R.E.; Kreoff, E.P.; Hoffman, I.A. and Frank, B.H. (1981) Diabetes Care, 4, 147.
31. Raptis, S. and Dimitriadis, G. (1985) Clin. Physiol. Biochem. 3, 29-42.
32. Heding, L.G. (1983) Acta Med. Scand. Suppl., 671, 107.
33. Sumra, M. and Gupta V.B. (1995) Indian Drugs, 32(8), 356.
34. Bhoraskar, A. (1994) J. Diabetic Assoc. India, 34(1), 42.
35. Barnett, A.H. and Owens, D.R. (1997) Lancet, 349, 47-51.
36. White, J.R.; Campbell, R.K. and Hirsch, I. (1997) Post. Grad. Med., 101, 58-70.
37. Home, P.D.; Lind Holm, A. and Riis A. (2000) Diabet. Med., 17, 762-770.
38. Hedman, C.A.; Lindstrom, T. and Arnqvist, H.J. (2001) Diabetes Care, 24, 1120-1121.
39. Ratner, R.E.; Hirsch, I.B.; Neifing, J.L.; Garg, S.K.; Mecca, T.E.; Wilson, C.A. (2000) Diabetes Care, 23, 639-643.
40. Yki-Jarvinen, H.; Dressier, A. and Zieman, M. (2001) Diabetes Care, 23, 1130-1136.
41. Duckworth, W. C.; Bennett, R.G. and Hamel, F.G. (1998), Endocr. Rev. 19, 608-24.
42. Gowthamarjan, K.; Kulkarni, J.T.; Rajan S.D. and Suresh, B. (2003) Ind. J. Pharm. Sci. 65(2), 176-179.
43. Saffran, M. and Kumar, G.S. (1986) Science, 233, 1081.
44. Trenktrog, T. and Muller, B.W. (1995) Int. J. Pharm., 123, 199.
45. Al-Alchi, A. and Greenwood, R. (1993) Drug Dev. Ind. Pharm., 19(6), 673.
46. Al-Alchi, A. and Greenwood, R. (1993) Drug Dev. Ind. Pharm., 19(11), 673.
47. Roques, M.; Cremel, G.; Aunis, D. and Hubert, P. (1995) Diabetologia, 38, 180.
48. Damge, C. and Michael, C. (1998) Diabetes, 37, 246.
49. Stefanov, A.V.; Kononenko, N.I.; Lishko, V.K. and Shevshenko, A.V. (1980) Ukr. Biokhim. Zh., 52, 497.
50. Jacobs, M.A.; Schreuder, R. H.; Jap, A.J.K.; Nauta, J.J.; Andersen P.M. and Heine R.J. (1993) Diabetes, 42, 1649-55.
51. Drejer, K.; Vaag, A.; Bech, K.; Hansen, P.; Sorensen, A.R. and Mygind, N. (1992) Diabetic Med., 9, 335-40.
52. Hilsted, J.; Madsbad, S.; Hvidberg, A.; Rasmussen, M.H.; Krarup, T.; Ipsen, H.; Hansen, B.; Pedersen M.; Djurup, R. and Oxenbull B. (1995) Diabetologia, 38, 680-4.
53. Nolte, M.S.; Taboga, C.; Salamon, E.; Moses, A.; Longenecker, J.; Flier, J. and Karam, J.H. (1990) Horm. Metab. Res., 22, 170-4.
54. Coates, P.A.; Ismail, I.S.; Luzio, S.D.; Griffith, I.; Ollerton, R.L.; Volund, A. and Owens D.R. (1995) Diabetic Med., 12, 235-9.
55. Andersen, P.M. (1993) In: Frontiers in Insulin Pharmacology, Berger M, Gries FA (Eds), Thieme Verlag, 126-36.
56. Olsen, C.L.; Liu, G. and Charles A. (1994) Novel routes of insulin delivery. In The Diabetes Annual/8. Marshall SM, Home PD, Eds. Amsterdam, London, New York, Tokyo, Elsevier, p. 243-276
57. Ali, A. and Trehan, A. (1998) Drug Dev. Ind. Pharm., 24(7), 589-597.
58. Illum, L.; Farraj, N.F. and Davis, S.S. (1994) Pharm. Res., 11, 1186-1189
59. Dodane, V.; Khan, M.A. and Merwin, J.R. (1999) Int. J. Pharm., 182, 21-32.
60. Farraj, N.F.; Illum, L.; Davis, S.S. and Johansen, B.R. (1989) Diabetologia, 32, 486.
61. Gordon, G.S.; Moses A.C.; Silver, R.D.; Flier, J.C. and Carey, M.C. (1985) Proc. Natl. Acad. Sci. USA, 82, 7419-23.
62. Moses, A.C.; Gordon, G.S.; Carey, M.C. and Flier, J.S. (1983) Diabetes, 32, 1040-7.
63. Merkus, F.E.W.; Verhoef, J.C.; Romeijn, S.G. and Schipper, N.G. (1991) Pharm. Res., 8, 588-92.
64. Watanabe, Y.; Matsumoto, Y.; Kawamoto, K.; Yazawa S. and Matsumoto, M. (1992) Chem. Pharm. Bull., Tokyo, 40, 3100-4.
65. Mishima, M.; Wakita, Y.; and Nakano, M. (1987) J. Pharmacobiodvn., 10, 624-31.
66. Mishima, M.; Okada, S.; Wakita, Y. and Nakano M. (1989) J. Pharmacobiodvn., 12, 31-34.
67. Lee, W.A.; Narog, B.A.; Patapoff, T.W. and Wang, Y.J. (1991) J. Pharm. Sci., 80, 725-729.
68. Etr, M.E.; Slama, G.; Desplanque, N. (1987) Lancet, 2, 1085-1086.
69. Wall, D.A. (1995) Drug Delivery 2, 1-20.
70. Byron, P.R. and Patton J.S. (1994) J. Aerosol. Med., 7, 49-75.
71. Köhler D. (1990) Lung, 14, 677-84.
72. Wigley, F.N.; Londono, J.H.; Shipp, J.C. and Waldman, R.H. (1971) Diabetes, 20, 552.
73. Kohlar, D. and Enzmann, F. (1984) Diabetes, 33(1), 298.
74. Heinemann, L.; Pfützner, A. and Heise, T. (2001) Curr. Pharm. Design, 7, 1327-1351.
75. Wolff, R.K. (1998) J. Aerosol. Med., 11, 197-219.
76. Owens, D.R. (2002) Nature Reviews, 1, 529-540.
77. Langkjaer, L.; Branje, J.; Grodsky, G.M. and Guy, R.H. (1998) J. Control. Rel., 51, 47-56.
78. Mitragotri, S.; Blankschtein, D. and Langer, R. (1995) Science, 269, 850-853.
79. Sevastianov, V.L.; Salomantia, L.A.; Ruznetsova, E.G.; Iakaleva, N.V. and Shumakov, V.I. (2003) Med. Teck., 4, 21.
80. Cevc, G. (1996) Crit. Rev. Ther. Drug Carrier Syst., 13, 257-288.
81. Godin, B. and Touitou, E. (2003) Crit. Rev. Ther. Drug Carrier Syst., 20(1), 63-102
82. Sadikot, S.M. (1992) J. Diabetic Assoc. India, 32(1), 15.
83. Hussain, M.A.; Aungust, B.J. and Sheffer, E. (1986) Eur. J. Pharm. Sci., 75, 218.
84. Modi, P.; Mihic, M. and Lewin, A. (2002) Diabetes Metab. Res. Rev., 18, S38-42.
85. Aungust, B.J.; Rogers, N.J. and Sheffer, E. (1988) J. Pharm. Exp. Ther., 23, 244.
86. Yamasaki, Y.; Shichiri, M.; Kawamori, R.; Kikuchi, M.; Yagi, T.; Arai, S.; Tohdo, R.; Hakui, N.; Oji, N. and Abe, H. (1981) Diabetes Care, 4(4), 454-458.
87. Horbett, T.A.; Kost, T. and Ratner, B.D. (1983) Am. Chem. Soc. Div. Polym. Chem. Prep., 24, 34.
88. Horbett, T.A.; Kost, T. and Ratner, B.D. (1984) A bioresponsive membrane for insulin delivery, in Recent Advances in Drug Delivery Systems, (Anderson J.M. and Kim, S.W., Eds), Plenum Press, New York, pp. 209.
89. Albin, G.; Horbett, T.A. and Ratner, B.D. (1986) Glucose sensitive membrane for controlled delivery of insulin, in Advances in Drug Delivery Systems, (Anderson J.M. and Kim, S.W., Eds), Elsevier, Amsterdam, p.p- 153.
90. Harban, P.A.; Kahn, S.E.; Lernmark, A. and Rhodes, C. J. (2001) Diabetes, 50(10), 2181-2191.
91. Robertson, R.P.; Lanz, K.J.; Sutherl, D.E. and Kendall, D.M. (2001) Diabetes, 50, 47-50.
92. Gruessner, R.W.; Sutherland, D.E.; Drangstveit, M.B.; Troppmann, C. and Gruessner, A.C. (1996) Transpl. Int., 9, 251-257.
93. Gruessner, R.W. (1997) Clin. Transplant., 11, 299-312.
94. Sutherland, D.E.; Goetz, F.C. and Sibley, R.K. (1989) Diabetes, 38(1), 85-87.
95. Keymeulen, B.; Ling, Z.; Gorus, F.K.; Delvaux, G.; Bouwens, L.; Grupping, A.; Hendrieckx, C.; Pipe leers, M.M.; Van, S.C.; Salmela, K. and Pipeleers, D.G. (1998) Diabetologia, 41, 452-459.
96. Garfinkel, M.R.; Harland, R.C.; Robert, C. and Opara, E.C. (1998) J. Surg. Res., 76, 7-10.
97. Gray, D.W.R. and Morris, P.I. (1986) World J. Surgery, 10, 21.
98. Morris, P.I. and Gray, W.R. (1989) Brit. Med. Bull., 45(1), 224.
99. Houwing, H.; Benthen, L.; Van Snylicher, P.T.R.; Vander leest, J.; Strubbe, J.H. and Steffers, A.B. (1995), Diabetologia, 38, 919.
100. Meoni, C.; Bertuzzi, F.; Pontiroli, A.E.; Falqui, L.; Monaco. L.; Soria, M.; Arcelloni, C.; Paroni, R.; Foglieni, C.; Polastri, L.; Galbiati, F.; Folli, F. and Davalli, A.M. (2000) Cell Transplant., 9, 829-840.
101. Lumelsky, N.; Blondel, O.; Laeng, P.; Velasco, I.; Ravin, R. and McKay, R. (2001) Science, 292, 1389-1394.
102. Assady, S.; Maor, G.; Amit, M.; Itskovitz, E.J.; Skorecki, K.L. and Tuckerman, M. (2001) Diabetes, 50, 1691-1697.
103. Bonner, W.S.; Taneja, M.; Weir, G.C.; Tatarkiewicz, K.; Song, K.H.; Sharma, A. and O'Neil J.J. (2000) Proc. Natl. Acad. Sci. USA, 97, 7999-8004.
104. Owerbach, D.; Bell, G.I.; Rutter, W.J.; Brown, J.A. and Shows, T.B. (1981) Diabetes, 30(3) 267-270.
105. Ji-Woon, Y. and Hee-Sook, J. (2002) Trends in Molecular Medicine, 8(2), 62-68.
106. Riu, E.; Mas, A.; Ferre, T.; Pujol, A.; Gros, L.; Otaegui, P., Montoliu, L. and Bosch, F. (2002), Diabetes, 51, 704-11.
107. Dong, H.; Altomonte, J.; Morral, N.; Meseck, M. and Thung, S.N. (2002) Diabetes, 51, 130-8.
108. Kay, M.A.; Glorioso, J.C. and Naldini L. (2001) Nat. Med. 7, 33-40.
109. Walther, W. and Stein, U. (2000) Drugs, 60, 249-271
110. Nagamatsu, S.; Nakamanchi, Y.; Ohara-Imaizumi, M.; Ozawa, S.; Katharia, H., Watanable, T. and Ishida, H. (2001) FEBS Lett., 509, 106-10.
111. Morsy, M.A. and Caskey, C.T. (1999) Mol. Med. Today 5, 18-24.
112. Tian, C.; Jessamyn, B.; Cretin, N.; Seth, N.; Wucherpfennig, K.W. and Iocomini, J. (2004), J. Clin. Invest., 114, 969-978.
113. Lin-Sui, K.; Kukreja, A. and Maclaren, N.K. (2001) Diabetes Technol. Ther., 3, 451-61.
114. Gearon, C.L.; Hussain, M.J. and Vergani, D. (1997) Diabelologia, 40, 1388-95.
115. Martins, T.C. and Aguas, A.P. (1999) Clin. Exp. Immunol, 115, 248-54.
116. Keller, R.J.; Eisenbarth, G.S. and Jackson, R.A. (1993) Lancet, 341, 927-8.
117. Rabinovitch, A.; Suarez-Pinzon, W.L.; Shaprio, A.M; Rajotte, R.V. and Power, R. (2002) Diabetes 51, 638-45.
118. Tisch, R.; Wang, B. and Weaver, D.J. (2001) J. Immunol., 166, 2122-2.
119. Bot, A.; Smith, D. and Bot, S. (2001) J. Immunol., 167, 2950-5.
120. Maxon, R.; Melican, N. S. and Weiner, H.L. (1999) J. Autoimmune., 12, 251-8.
121. Polanski, M.; Melican, N. S.; Zhang, J. and Weiner, H.L. (1997) J. Autoimmune., 10, 339-46.